Skip to main content
Year archive

HEMOGENYX PHARMACEUTICALS PLC — 2019 filings

All 23 regulatory filings released by HEMOGENYX PHARMACEUTICALS PLC (HEMO) in 2019, sourced directly from the official regulator.

23 Filings
2019 Period
2019 filings (23)
Filing Released Lang
Operational Update
Regulatory Filings
2019-11-18 English
Presentation at the Investival Showcase
Regulatory Filings
2019-11-12 English
Presentation at the NY Oncology Investor Conf.
Regulatory Filings
2019-11-06 English
Research Agreement with Global Pharma Company
Regulatory Filings
2019-10-23 English
Presentation at NY Stem Cell Foundation conference
Report Publication Announcement
2019-10-21 English
Half-year Report
Interim / Quarterly Report H1 2019
2019-09-30 English
Hemogenyx scientific advisor receives Lasker Award
Regulatory Filings
2019-09-12 English
Total Voting Rights
Regulatory Filings
2019-08-01 English
CDX Patent Application
Regulatory Filings
2019-07-12 English
Result of AGM
AGM Information
2019-06-28 English
Development of ApbHC
Regulatory Filings
2019-06-24 English
Group of companies' accounts made up to 2018-12-31
Regulatory Filings
2019-06-17 English
CDX Effective as Conditioning Therapeutic in vivo
Regulatory Filings
2019-06-12 English
CDX Antibody is Effective against AML in vivo
Earnings Release FY 2019
2019-06-05 English
Second Price Monitoring Extn
Regulatory Filings
2019-05-30 English
Price Monitoring Extension
Regulatory Filings
2019-05-30 English
CDX Antibody is Effective against ALL in vitro
Legal Proceedings Report
2019-05-30 English
Posting of Annual Report and Notice of AGM
Report Publication Announcement
2019-05-28 English
Variation of Terms of Warrant Instrument
Regulatory Filings
2019-05-15 English
Director/PDMR Shareholding
Director's Dealing
2019-05-01 English
Final Results for the Year Ended 31 December 2018
Annual Report FY 2018
2019-04-29 English
Presentation at Cancer Immunotherapy Conference
Regulatory Filings
2019-01-30 English
Operations Update
Regulatory Filings
2019-01-07 English